Tyenne Injection, Solution
Product Images NDC 65219-596

Product Visual Gallery

This gallery contains 67 technical images submitted to the FDA as part of the official labeling for Tyenne (NDC 65219-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tocli-img-01.jpg (Tocil Img 01)

FDA Label Image

Tocli-img-02.jpg (Tocil Img 02)

FDA Label Image

Tocli-img-03.jpg (Tocil Img 03)

This text is not available.*

FDA Label Image

Tocli-img-04.jpg (Tocil Img 04)

This is a product description for a clear cap window body medicine container.*

FDA Label Image

Tocli-img-05.jpg (Tocil Img 05)

FDA Label Image

Tocli-img-06.jpg (Tocil Img 06)

Prepare for your injection*

FDA Label Image

Tocli-img-07.jpg (Tocil Img 07)

FDA Label Image

Tocli-img-08.jpg (Tocil Img 08)

FDA Label Image

Tocli-img-09.jpg (Tocil Img 09)

FDA Label Image

Tocli-img-10.jpg (Tocil Img 10)

FDA Label Image

Tocli-img-11.jpg (Tocil Img 11)

This text is not available.*

FDA Label Image

Tocli-img-12.jpg (Tocil Img 12)

FDA Label Image

Tocli-img-13.jpg (Tocil Img 13)

FDA Label Image

Tocli-img-14.jpg (Tocil Img 14)

FDA Label Image

Tocli-img-15.jpg (Tocil Img 15)

FDA Label Image

Tocli-img-16.jpg (Tocil Img 16)

FDA Label Image

Tocli-img-17.jpg (Tocil Img 17)

FDA Label Image

Tocli-img-18.jpg (Tocil Img 18)

FDA Label Image

Tocli-img-19.jpg (Tocil Img 19)

Clean the injection site.*

FDA Label Image

Tocli-img-20.jpg (Tocil Img 20)

FDA Label Image

Tocli-img-21.jpg (Tocil Img 21)

FDA Label Image

Tocli-img-22.jpg (Tocil Img 22)

FDA Label Image

Tocli-img-23.jpg (Tocil Img 23)

FDA Label Image

Tocli-img-24.jpg (Tocil Img 24)

FDA Label Image

Tocli-img-25.jpg (Tocil Img 25)

FDA Label Image

Tocli-img-26.jpg (Tocil Img 26)

FDA Label Image

Tocli-img-27.jpg (Tocil Img 27)

FDA Label Image

Tocli-img-28.jpg (Tocil Img 28)

FDA Label Image

Tocil-img-29.jpg (Tocil Img 29)

FDA Label Image

Tocli-img-30.jpg (Tocil Img 30)

FDA Label Image

Tocli-img-31.jpg (Tocil Img 31)

FDA Label Image

Tocli-img-32.jpg (Tocil Img 32)

FDA Label Image

Tocli-img-33.jpg (Tocil Img 33)

Not available.*

FDA Label Image

Tocli-img-34.jpg (Tocil Img 34)

FDA Label Image

Tocli-img-35.jpg (Tocil Img 35)

FDA Label Image

Tocli-img-36.jpg (Tocil Img 36)

This is a set of instructions for using Tyenne Injection, which is a single-dose prefilled syringe containing 162 mg/0.9 mL of a substance for subcutaneous use. It is important to read these instructions carefully before using the product.*

FDA Label Image

Tocli-img-37.jpg (Tocil Img 37)

This is a set of instructions for a syringe with important details for use. It features a front view image for reference and descriptions of components like the clear needle guard plunger, finger flange, and needle guard spring. Additionally, it mentions the importance of checking the expiration date before using it.*

FDA Label Image

Tocli-img-38.jpg (Tocil Img 38)

FDA Label Image

Tocli-img-39.jpg (Tocil Img 39)

FDA Label Image

Tocli-img-40.jpg (Tocil Img 40)

FDA Label Image

Tocli-img-41.jpg (Tocil Img 41)

FDA Label Image

Tocli-img-42.jpg (Tocil Img 42)

FDA Label Image

Tocli-img-43.jpg (Tocil Img 43)

FDA Label Image

Tocli-img-44.jpg (Tocil Img 44)

FDA Label Image

Tocli-img-45.jpg (Tocil Img 45)

FDA Label Image

Tocli-img-46.jpg (Tocil Img 46)

FDA Label Image

Tocli-img-47.jpg (Tocil Img 47)

FDA Label Image

Tocli-img-48.jpg (Tocil Img 48)

This text indicates the importance of selecting an appropriate site for an injection. Proper injection site selection is crucial for the effectiveness and safety of the medication being administered.*

FDA Label Image

Tocli-img-49.jpg (Tocil Img 49)

FDA Label Image

Tocli-img-50.jpg (Tocil Img 50)

FDA Label Image

Tocli-img-51.jpg (Tocil Img 51)

FDA Label Image

Tocli-img-52.jpg (Tocil Img 52)

FDA Label Image

Tocli-img-53.jpg (Tocil Img 53)

FDA Label Image

Tocli-img-54.jpg (Tocil Img 54)

FDA Label Image

Tocli-img-55.jpg (Tocil Img 55)

FDA Label Image

Tocli-img-56.jpg (Tocil Img 56)

FDA Label Image

Tocli-img-57.jpg (Tocil Img 57)

FDA Label Image

Tocli-img-58.jpg (Tocil Img 58)

FDA Label Image

Tocli-img-59.jpg (Tocil Img 59)

FDA Label Image

Tocli-img-60.jpg (Tocil Img 60)

FDA Label Image

Tocli-img-61.jpg (Tocil Img 61)

FDA Label Image

Tocli-img-62.jpg (Tocil Img 62)

FDA Label Image

Tocli-img-63.jpg (Tocil Img 63)

FDA Label Image

Tocli-label-01.jpg (Tocil Label 01)

This is a prescription injection for subcutaneous use manufactured by Fresenius Kabi USA, LLC. The label includes the lot number and expiration date.*

FDA Label Image

Tocil-label-02.jpg (Tocil Label 02)

FDA Label Image

Tocil-label-03.jpg (Tocil Label 03)

This is a prescription medication with the National Drug Code (NDC) 65219-596-01. It is an injection containing 162 mg for subcutaneous use only. Manufactured by Fresenius Kabi USA, LLC, with US License No. 2146.*

FDA Label Image

Tocil-label-04.jpg (Tocil Label 04)

The text contains information about an autoinjector medication called Tyenne, with the active ingredient tocilizumab-azag, indicated for subcutaneous use. It includes details on its contents, storage conditions, manufacturer (Fresenius Kabi USA, LLC), and instructions for use. The autoinjector is to be stored refrigerated and should not be frozen or shaken. It can be stored at room temperature for up to a maximum of 77°F for 14 days. The text provides details on the inactive ingredients and advises consulting prescribing information before use. It also mentions recording the date of removal from the refrigerator and discarding any unused portion.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.